Long-term follow-up results of the ZUMA-1 trial of anti-CD19 CAR T-cells for non-Hodgkin lymphoma
New endpoints in clinical trials to better serve patients
Elihu H. Estey
Is autologous stem cell transplantation still the backbone of multiple myeloma treatment?
Primary analysis of MURANO study data for R/R CLL
Mantle cell lymphoma highlights from ASH 2016: Lysa, PHILEMON results and more